Amplify Seymour Cannabis ETF
CNBS
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 3333 Warrenville Road, #350 Lisle IL United States of America 60532
- IPO Date
- Jul 23, 2019
- CIK
- 0001633061
- Website
- amplifyetfs.com
- Similar Companies
- Business
- Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund that seeks capital appreciation by investing at least 80% of its net assets in securities of U.S. companies deriving 50% or more of their revenue from the cannabis and hemp ecosystem, as well as derivatives providing similar economic exposure; these investments span three primary classifications including Cannabis/Hemp Plant (pharmaceuticals/biotechnology, cultivation and retail, hemp products, cannabis-infused products), Support (agricultural technology, real estate, commercial services), and Ancillary (consumption devices/mechanisms, investing and finance, technology and media, other ancillary sectors). The fund primarily holds equity securities and total return swaps on cannabis-related companies such as Curaleaf Holdings, Inc., TerrAscend Corp., Trulieve Cannabis, Green Thumb Industries, and Verano Holdings, alongside U.S. Treasury Bills for collateral and cash equivalents like Invesco Government & Agency Portfolio; it targets companies listed on major exchanges including NYSE, Nasdaq, TSX, and others, with portfolio holdings typically ranging from 20 to 45 securities meeting liquidity and market capitalization thresholds. CNBS operates in the thematic ETF segment focused on the emerging global cannabis and hemp industries, providing exposure to small-, mid-, and large-cap companies across developed and emerging markets, with significant emphasis on U.S. and Canadian issuers serving cultivators, retailers, pharmaceutical developers, and ancillary service providers. Launched on July 23, 2019, and listed on NYSE Arca, the ETF is issued by Amplify ETF Trust and managed by Amplify Investments LLC (headquartered at 3333 Warrenville Road, Suite 350, Lisle, Illinois), with sub-advisory services from Seymour Asset Management LLC (led by portfolio manager Tim Seymour) and Tidal Financial Investments LLC. Geographically, the fund invests in securities from U.S.-based companies and non-U.S. issuers via ADRs or GDRs, with primary exposure to North American markets including Canada, while adhering to legal compliance in jurisdictions of operation and avoiding direct holdings in U.S. marijuana cultivators due to federal restrictions. Recent developments include a 1-for-12 reverse share split effective February 21, 2025, to address share price levels; sub-adviser changes approved in November 2024 terminating Penserra Capital Management LLC and appointing Tidal Investments LLC alongside Seymour Asset Management LLC; and a refined 80% investment policy effective around January 28, 2025, emphasizing U.S. cannabis and hemp revenue derivation with active portfolio adjustments based on regulatory, macroeconomic, and company-specific factors. The fund maintains a net expense ratio of 0.76% after waivers through March 1, 2026, and reported net assets of approximately $69.7 million as of March 31, 2025, with a portfolio turnover of 17%.